MORRISVILLE, NC — Endovascular device maker Arrow International has announced a voluntary class I recall of some of its intra-aortic balloon catheter and percutaneous insertion kits[1].
The FDA has been notified of the recall of about 47,000 units (product codes and lot numbers) sent to hospitals around the world, according to the company's letter to its customers dated February 11, 2016 and distributed by parent company Teleflex.
The recall is "due to the possibility that the sheath body may become separated from the sheath hub. If the separation occurs, there is a potential for bleeding from the device. If bleeding is not addressed with prompt intervention, it may result in loss of significant blood volume or exsanguination. In addition, delay of treatment, interruption of treatment, or loss of [intra-aortic balloon] IAB therapy can occur."
Heartwire from Medscape © 2016
Medscape Medical News © WebMD, LLC
Heartwire © WebMD, LLC
WebMD Health News © WebMD, LLC
Reuters Health Information ©
Send comments and news tips to news@medscape.net.
Cite this: Arrow Recalls Intra-Aortic Balloon Catheter Kits - Medscape - Mar 11, 2016.
Comments